Research study Program year 2023 Source: CMS Open Payments

A Phase 2B, Open-Label Long-Term Durability Study of CCH Following Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite)

Research payments

$1,583,733

222 payments

Through program year 2023, $1,583,733 in research payments was reported against A Phase 2B, Open-Label Long-Term Durability Study of CCH Following Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite), across 222 payments, paid by Endo Pharmaceuticals Inc..

Paid by: Endo Pharmaceuticals Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$583,039	120
2022	Research	$976,232	94
2020	Research	$24,461	8

Breakdown

Who paid Research payments · program years 2020–2023

Endo Pharmaceuticals Inc. $1,583,733 222 payments

Who received the money Research payments · program years 2020–2023

Austin Institute For Clinical Research INC Organisation paid for research $278,693 26 payments
Luxurgery LLC Organisation paid for research $255,972 37 payments
California Dermatology & Clinical Research Institute Organisation paid for research $199,560 19 payments
Dermatology Cosmetic Laser Medical Associates of La Jolla Inc Organisation paid for research $182,644 19 payments
Tennessee Clinical Research Center Organisation paid for research $129,024 16 payments
Dermatology Nola Organisation paid for research $117,183 13 payments
Denova Research Organisation paid for research $89,200 17 payments
Lawrence J Green MD Llc Organisation paid for research $88,478 8 payments
Investigate MD LLC Organisation paid for research $71,400 14 payments
Skin Research Institute LLC Organisation paid for research $64,941 16 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.